Julia Zima

Pooled analysis of large and long‐term safety data from the human papillomavirus‐16/18‐AS04‐adjuvanted vaccine clinical trial programme

Maria‐Genalin Angelo, Marie‐Pierre David, Julia Zima et al. · Pharmacoepidemiology and Drug Safety · 2014 · 94 citations · Full text

Veterinary Medicine, Infectious Diseases, Obstetrics +15

Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom

Corinne Willame, Dominique Rosillon, Julia Zima et al. · Human Vaccines & Immunotherapeutics · 2016 · 54 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom

Laurence Baril, Dominique Rosillon, Corinne Willame et al. · Vaccine · 2015 · 42 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial

Matti Lehtinen, Tiina Eriksson, Dan Apter et al. · Human Vaccines & Immunotherapeutics · 2016 · 32 citations · Full text

Medicine, Child Health, Pediatrics +16

Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data

Frank Huygen, Kristin Verschueren, Jens‐Ulrich Stegmann et al. · EBioMedicine · 2015 · 22 citations · Full text

Medicine, Preventive Medicine, Immunization +16